Corticotropin releasing hormone as an identifier of bronchiolitis obliterans syndrome

Corticotropin releasing hormone as an identifier of bronchiolitis obliterans syndrome

Abstract Lung transplantion (LTx) recipients have low long-term survival and a high incidence of bronchiolitis obliterans syndrome (BOS), an inflammation of the small airways in chronic rejection of a lung allograft. There is great clinical need for a minimally invasive biomarker of BOS. Here, 644 d...

Full description

Bibliographic Details
Main Authors: Anna Niroomand, Haider Ghaidan, Oskar Hallgren, Lennart Hansson, Hillevi Larsson, Darcy Wagner, Martina Mackova, Kieran Halloran, Snejana Hyllén, Sandra Lindstedt
Format: Article
Language:English
Published: Nature Portfolio 2022-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-12546-1

Internet

https://doi.org/10.1038/s41598-022-12546-1

Similar Items